<VariationArchive VariationID="648624" VariationName="NM_000018.4(ACADVL):c.307_323dup (p.Val109fs)" VariationType="Duplication" Accession="VCV000648624" Version="15" RecordType="classified" NumberOfSubmissions="5" NumberOfSubmitters="5" DateLastUpdated="2024-06-23" DateCreated="2019-08-14" MostRecentSubmission="2024-06-17">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="646647" VariationID="648624">
      <GeneList>
        <Gene Symbol="ACADVL" FullName="acyl-CoA dehydrogenase very long chain" GeneID="37" HGNC_ID="HGNC:92" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>17p13.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="7217125" stop="7225266" display_start="7217125" display_stop="7225266" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="7120443" stop="7128585" display_start="7120443" display_stop="7128585" Strand="+" />
          </Location>
          <OMIM>609575</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000018.4(ACADVL):c.307_323dup (p.Val109fs)</Name>
      <CanonicalSPDI>NC_000017.11:7220794:AAAGAGCTGGTGGAGCC:AAAGAGCTGGTGGAGCCAAAGAGCTGGTGGAGCC</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>17p13.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="7124113" stop="7124114" display_start="7124113" display_stop="7124114" variantLength="17" positionVCF="7124113" referenceAlleleVCF="T" alternateAlleleVCF="TAAAGAGCTGGTGGAGCC" />
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="7220794" stop="7220795" display_start="7220794" display_stop="7220795" variantLength="17" positionVCF="7220794" referenceAlleleVCF="T" alternateAlleleVCF="TAAAGAGCTGGTGGAGCC" />
      </Location>
      <OtherNameList>
        <Name>NM_000018.4(ACADVL):c.307_323dup</Name>
        <Name>p.Val109fs</Name>
      </OtherNameList>
      <ProteinChange>V109fs</ProteinChange>
      <ProteinChange>V132fs</ProteinChange>
      <ProteinChange>V33fs</ProteinChange>
      <ProteinChange>V87fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000017.10" sequenceAccession="NC_000017" sequenceVersion="10" change="g.7124114_7124130dup" Assembly="GRCh37">
            <Expression>NC_000017.10:g.7124114_7124130dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000017.11" sequenceAccession="NC_000017" sequenceVersion="11" change="g.7220795_7220811dup" Assembly="GRCh38">
            <Expression>NC_000017.11:g.7220795_7220811dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007975.1" sequenceAccession="NG_007975" sequenceVersion="1" change="g.5962_5978dup">
            <Expression>NG_007975.1:g.5962_5978dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008391.2" sequenceAccession="NG_008391" sequenceVersion="2" change="g.4240_4256dup">
            <Expression>NG_008391.2:g.4240_4256dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000018.4" sequenceAccession="NM_000018" sequenceVersion="4" change="c.307_323dup" MANESelect="true">
            <Expression>NM_000018.4:c.307_323dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000009.1" sequenceAccession="NP_000009" sequenceVersion="1" change="p.Val109fs">
            <Expression>NP_000009.1:p.Val109fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001033859.3" sequenceAccession="NM_001033859" sequenceVersion="3" change="c.241_257dup">
            <Expression>NM_001033859.3:c.241_257dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001029031.1" sequenceAccession="NP_001029031" sequenceVersion="1" change="p.Val87fs">
            <Expression>NP_001029031.1:p.Val87fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001270447.2" sequenceAccession="NM_001270447" sequenceVersion="2" change="c.376_392dup">
            <Expression>NM_001270447.2:c.376_392dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001257376.1" sequenceAccession="NP_001257376" sequenceVersion="1" change="p.Val132fs">
            <Expression>NP_001257376.1:p.Val132fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001270448.2" sequenceAccession="NM_001270448" sequenceVersion="2" change="c.79_95dup">
            <Expression>NM_001270448.2:c.79_95dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001257377.1" sequenceAccession="NP_001257377" sequenceVersion="1" change="p.Val33fs">
            <Expression>NP_001257377.1:p.Val33fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000018.3" sequenceAccession="NM_000018" sequenceVersion="3" change="c.307_323dup17">
            <Expression>NM_000018.3:c.307_323dup17</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="1597520263" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000018.4(ACADVL):c.307_323dup (p.Val109fs) AND Very long chain acyl-CoA dehydrogenase deficiency" Accession="RCV000803389" Version="14">
        <ClassifiedConditionList TraitSetID="417">
          <ClassifiedCondition DB="MedGen" ID="C3887523">Very long chain acyl-CoA dehydrogenase deficiency</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>reviewed by expert panel</ReviewStatus>
            <Description DateLastEvaluated="2022-04-26" SubmissionCount="4">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000018.4(ACADVL):c.307_323dup (p.Val109fs) AND ACADVL-related disorder" Accession="RCV003392608" Version="4">
        <ClassifiedConditionList TraitSetID="90836">
          <ClassifiedCondition>ACADVL-related disorder</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-08-26" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-04-26" NumberOfSubmissions="5" NumberOfSubmitters="5" DateCreated="2019-08-14" MostRecentSubmission="2024-06-17">
        <ReviewStatus>reviewed by expert panel</ReviewStatus>
        <Description>Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">11590124</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9973285</ID>
        </Citation>
        <Citation Type="general">
          <URL>https://erepo.clinicalgenome.org/evrepo/ui/interpretation/c062cd76-3206-4704-b9df-e35fd81dae28</URL>
        </Citation>
        <DescriptionHistory Dated="2022-10-05">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="90836" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="69347" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">ACADVL-related condition</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">ACADVL-related disorder</ElementValue>
              </Name>
            </Trait>
          </TraitSet>
          <TraitSet ID="417" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="27" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Very long chain acyl-CoA dehydrogenase deficiency</ElementValue>
                <XRef ID="VLCAD+deficiency/7410" DB="Genetic Alliance" />
                <XRef ID="MONDO:0008723" DB="MONDO" />
                <XRef ID="237997005" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">VLCAD deficiency</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">VLCADD</ElementValue>
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">VLCAD</ElementValue>
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">ACADVLD</ElementValue>
                <XRef Type="MIM" ID="201475" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Deficiency of very long-chain acyl-coenzyme A dehydrogenase (VLCAD), which catalyzes the initial step of mitochondrial beta-oxidation of long-chain fatty acids with a chain length of 14 to 20 carbons, is associated with three phenotypes. The severe early-onset cardiac and multiorgan failure form typically presents in the first months of life with hypertrophic or dilated cardiomyopathy, pericardial effusion, and arrhythmias, as well as hypotonia, hepatomegaly, and intermittent hypoglycemia. The hepatic or hypoketotic hypoglycemic form typically presents during early childhood with hypoketotic hypoglycemia and hepatomegaly, but without cardiomyopathy. The later-onset episodic myopathic form presents with intermittent rhabdomyolysis provoked by exercise, muscle cramps and/or pain, and/or exercise intolerance. Hypoglycemia typically is not present at the time of symptoms.</Attribute>
                <XRef ID="NBK6816" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="5508" />
                <XRef ID="5508" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301763</ID>
                <ID Source="BookShelf">NBK6816</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="GMDI/SERN, 2021">
                <URL>https://managementguidelines.net/guidelines.php/130/VLCAD%20Nutrition%20Guidelines/Version%201.1</URL>
                <CitationText>VLCAD Nutrition Management Guidelines</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2022">
                <URL>https://www.acmg.net/PDFLibrary/C14.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Newborn Screening ACT Sheet, Elevated C14:1 +/- other long-chain acylcarnitines, Very Long-Chain Acyl-CoA Dehydrogenase (VLCAD) Deficiency, 2022</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="GMDI, 2022">
                <URL>https://managementguidelines.net/guidelines.php/146/VLCAD%20Nutrition%20Guidelines/Version%201.4</URL>
                <CitationText>GMDI (SERN), VLCAD Nutrition Management Guidelines, v. 1.4, 2022</CitationText>
              </Citation>
              <XRef ID="26793" DB="Orphanet" />
              <XRef ID="C3887523" DB="MedGen" />
              <XRef ID="MONDO:0008723" DB="MONDO" />
              <XRef Type="MIM" ID="201475" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="2704090" SubmissionDate="2020-07-13" DateLastUpdated="2020-07-16" DateCreated="2020-07-16">
        <ClinVarSubmissionID localKey="NM_000018.3:c.307_323dup17|OMIM:201475" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV001364955" DateUpdated="2020-07-16" DateCreated="2020-07-16" Type="SCV" Version="2" SubmitterName="Wong Mito Lab, Molecular and Human Genetics, Baylor College of Medicine" OrgID="506302" OrganizationCategory="laboratory" OrgAbbreviation="WongLab-BCM" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-11-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The NM_000018.3:c.307_323dup17 (NP_000009.1:p.Val109LysfsTer14) [GRCH38: NC_000017.11:g.7220795_7220811dup] variant in ACADVL gene is interpretated to be Pathogenic based on ACMG guidelines (PMID: 25741868). This variant has been reported. This variant meets the following evidence codes reported in the ACMG guidelines: PVS1, PS3</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000018.3:c.307_323dup17</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="201475" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB7761254</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion FDARecognizedDatabase="true" ID="5037578" SubmissionDate="2023-04-11" DateLastUpdated="2023-04-23" DateCreated="2022-10-08">
        <ClinVarSubmissionID localKey="c062cd76-3206-4704-b9df-e35fd81dae28" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002576780" DateUpdated="2023-04-23" DateCreated="2022-10-08" Type="SCV" Version="2" SubmitterName="ClinGen ACADVL Variant Curation Expert Panel, ClinGen" OrgID="508473" OrganizationCategory="consortium" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-04-26">
          <ReviewStatus>reviewed by expert panel</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Citation>
            <URL>https://erepo.clinicalgenome.org/evrepo/ui/interpretation/c062cd76-3206-4704-b9df-e35fd81dae28</URL>
          </Citation>
          <Comment>The c.307_323dup, p.(Val109Lysfs*14) variant in ACADVL is a frameshift variant predicted to cause a premature stop codon in biologically-relevant-exon 6/20 leading to nonsense mediated decay in a gene in which loss-of-function is an established disease mechanism (PVS1; PMIDs 9973285, 11590124). This variant has been detected in one individual identified by abnormal newborn screening or presumed positive on newborn screening for very long chain acyl CoA dehydrogenase (VLCAD) deficiency with no reported follow-up plasma acylcarnitine or enzyme activity; a second distinct pathogenic or likely pathogenic variant in ACADVL was not reported in this individual (PMID: 26385305). This variant is absent from gnomAD v2.1.1 (PM2_Supporting). To our knowledge, functional assays have not been reported for this variant. In summary, this variant meets the criteria to be classified as LIKELY PATHOGENIC for autosomal recessive very long chain acyl-CoA dehydrogenase (VLCAD) deficiency based on the ACMG/AMP criteria applied, as specified by the ClinGen ACADVL Variant Curation Expert Panel: PVS1, PM2_Supporting (ClinGen ACADVL VCEP specifications version#2.0; approved 04-25-2022).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">clingen acadvl acmg specifications v1</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/iz6xgwit/clingen_acadvl_acmg_specifications_v1.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>curation</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ACADVL" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name>NM_000018.4(ACADVL):c.307_323dup</Name>
            <Name>p.Val109fs</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000017.11:g.7220795_7220811dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MONDO" ID="MONDO:0008723" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>ACADVL EP ClinVar Submission 2</SubmissionName>
          <SubmissionName>ACADVL updated April 2023 submission</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7693705" SubmissionDate="2023-10-19" DateLastUpdated="2023-11-20" DateCreated="2023-11-20">
        <ClinVarSubmissionID localKey="30117014|ACADVL-related condition" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004118677" DateUpdated="2023-11-20" DateCreated="2023-11-20" Type="SCV" Version="1" SubmitterName="PreventionGenetics, part of Exact Sciences" OrgID="239772" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-08-26">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The ACADVL c.307_323dup17 variant is predicted to result in a frameshift and premature protein termination (p.Val109Lysfs*14). This variant was reported in an individual who had a positive newborn screen for Very long chain acyl-CoA dehydrogenase deficiency (Miller et al 2015. PubMed ID: 26385305). This variant has not been reported in a large population database (http://gnomad.broadinstitute.org), indicating this variant is rare. Frameshift variants in ACADVL are expected to be pathogenic. This variant is interpreted as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ACADVL" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000018.3:c.307_323dup17</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">ACADVL-related condition</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13915440</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1837240" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2019-08-14">
        <ClinVarSubmissionID localKey="4935382|MedGen:C3887523" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000943258" DateUpdated="2024-02-14" DateCreated="2019-08-14" Type="SCV" Version="6" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-08-11">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">9973285</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">11590124</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. Loss-of-function variants in ACADVL are known to be pathogenic (PMID: 9973285, 11590124). This variant has been observed in an individual who was newborn screening¬† positive for VLCAD deficiency (PMID:¬†26385305). This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Val109Lysfs*14) in the ACADVL gene. It is expected to result in an absent or disrupted protein product.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ACADVL" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000017.10:g.7124113_7124114insAAAGAGCTGGTGGAGCC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C3887523" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7863470" SubmissionDate="2024-06-05" DateLastUpdated="2024-06-17" DateCreated="2023-12-30">
        <ClinVarSubmissionID localKey="NM_000018.4:c.307_323dup|OMIM:201475" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004216101" DateUpdated="2024-06-17" DateCreated="2023-12-30" Type="SCV" Version="2" SubmitterName="Baylor Genetics" OrgID="1006" OrganizationCategory="laboratory" OrgAbbreviation="BCM: BMGL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-01-25">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000018.4:c.307_323dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="201475" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GA_HC_20231102_20240331</SubmissionName>
          <SubmissionName>SUB13856327</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1837240" TraitType="Disease" MappingType="XRef" MappingValue="C3887523" MappingRef="MedGen">
        <MedGen CUI="C3887523" Name="Very long chain acyl-CoA dehydrogenase deficiency" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7693705" TraitType="Disease" MappingType="Name" MappingValue="ACADVL-related condition" MappingRef="Preferred">
        <MedGen CUI="None" Name="ACADVL-related disorder" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7863470" TraitType="Disease" MappingType="XRef" MappingValue="201475" MappingRef="OMIM">
        <MedGen CUI="C3887523" Name="Very long chain acyl-CoA dehydrogenase deficiency" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2704090" TraitType="Disease" MappingType="XRef" MappingValue="201475" MappingRef="OMIM">
        <MedGen CUI="C3887523" Name="Very long chain acyl-CoA dehydrogenase deficiency" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5037578" TraitType="Disease" MappingType="XRef" MappingValue="MONDO:0008723" MappingRef="MONDO">
        <MedGen CUI="C3887523" Name="Very long chain acyl-CoA dehydrogenase deficiency" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

